Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

131I-metaiodobenzylguanidine therapy of neuroblastoma and other neuroendocrine tumors.

Grünwald F, Ezziddin S.

Semin Nucl Med. 2010 Mar;40(2):153-63. doi: 10.1053/j.semnuclmed.2009.11.004. Review.

PMID:
20113683
2.

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

Mukherjee JJ, Kaltsas GA, Islam N, Plowman PN, Foley R, Hikmat J, Britton KE, Jenkins PJ, Chew SL, Monson JP, Besser GM, Grossman AB.

Clin Endocrinol (Oxf). 2001 Jul;55(1):47-60.

PMID:
11453952
3.

Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.

Kang TI, Brophy P, Hickeson M, Heyman S, Evans AE, Charron M, Maris JM.

J Pediatr Hematol Oncol. 2003 Oct;25(10):769-73.

PMID:
14528098
4.
5.

131I-MIBG therapy of neural crest tumours (review).

Troncone L, Rufini V.

Anticancer Res. 1997 May-Jun;17(3B):1823-31. Review.

PMID:
9179240
6.

Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.

Sari O, Uğur O, Emir S, Akyüz C.

Turk J Pediatr. 2001 Jan-Mar;43(1):29-33.

PMID:
11297155
7.

[Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].

Défachelles AS, Cougnenc O, Carpentier P.

Bull Cancer. 2011 May;98(5):559-69. doi: 10.1684/bdc.2011.1353. Review. French.

8.

131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.

Sywak MS, Pasieka JL, McEwan A, Kline G, Rorstad O.

World J Surg. 2004 Nov;28(11):1157-62.

PMID:
15490060
9.

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.

Wiseman GA, Kvols LK.

Semin Nucl Med. 1995 Jul;25(3):272-8. Review.

PMID:
7570046
10.

Nuclear medicine therapy of neuroblastoma.

Hoefnagel CA.

Q J Nucl Med. 1999 Dec;43(4):336-43. Review.

PMID:
10731784
11.

¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.

Bomanji JB, Papathanasiou ND.

Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S113-25. doi: 10.1007/s00259-011-2013-8. Review.

PMID:
22388626
12.

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

Matthay KK, Yanik G, Messina J, Quach A, Huberty J, Cheng SC, Veatch J, Goldsby R, Brophy P, Kersun LS, Hawkins RA, Maris JM.

J Clin Oncol. 2007 Mar 20;25(9):1054-60.

PMID:
17369569
13.

Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors.

Ezziddin S, Sabet A, Logvinski T, Alkawaldeh K, Yong-Hing CJ, Ahmadzadehfar H, Grünwald F, Biersack HJ.

J Nucl Med. 2013 Dec;54(12):2032-8. doi: 10.2967/jnumed.112.119313. Epub 2013 Oct 7.

14.

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM.

J Clin Oncol. 2006 Jan 20;24(3):500-6.

PMID:
16421427
15.
16.

[¹³¹I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologies.

Rachh SH, Abhyankar S, Basu S.

Nucl Med Commun. 2011 Dec;32(12):1201-10. doi: 10.1097/MNM.0b013e32834bad97.

PMID:
21968432
17.

Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.

Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman J, Onaitis MW, Tyler DS, Olson JA Jr.

Cancer. 2004 Nov 1;101(9):1987-93.

18.

Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy.

Nguyen C, Faraggi M, Giraudet AL, de Labriolle-Vaylet C, Aparicio T, Rouzet F, Mignon M, Askienazy S, Sobhani I.

J Nucl Med. 2004 Oct;45(10):1660-8.

19.

Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.

Garaventa A, Gambini C, Villavecchia G, Di Cataldo A, Bertolazzi L, Pizzitola MR, De Bernardi B, Haupt R.

Cancer. 2003 Mar 1;97(5):1332-8.

20.

Supplemental Content

Support Center